感染監視ソリューション市場- 世界の産業規模、シェア、動向、機会、予測、提供別（ソフトウェア、サービス）、エンドユーザー別（病院、長期ケア施設）、地域別、競合別、2020年～2030年

感染監視ソリューションの世界市場規模は、2024年に5億5,721万米ドルとなり、2030年までの予測期間のCAGRは11.16%で堅調な成長が予測されています。

感染サーベイランスソリューションは、病院を含むヘルスケア施設が患者データを州や連邦当局に報告するために使用するソフトウェアです。これらのソリューションは、院内感染に関するデータを収集し、感染パターンを研究し、コミュニティ内での感染拡大を規制することで、ヘルスケア業界で重要な役割を果たしています。院内感染とは、病院やヘルスケアセンター内で個人に感染する感染症のことです。このソフトウェアは、感染が発生した場合、病院のインターネット・プロトコル（IP）アドレスに迅速に警告を発します。これにより、HAIスペシャリストや看護師は、感染した患者に適切な治療を迅速に提供することができ、アウトブレイクを防ぐことができます。感染監視ソリューションは、ヘルスケア施設におけるヘルスケア感染症（HAI）の効果的な管理を促進する重要なプログラムです。

例えば、2024年に米国の病院データを分析した研究では、抗菌薬耐性（AMR）に関連する院内感染がCOVID-19パンデミック中に32%増加し、パンデミック後の感染率はパンデミック前のレベルと比較して13%高いままであることが明らかになりました。この調査結果は、パンデミックがAMRに与えた永続的な影響と、持続的な感染制御と抗菌薬スチュワードシップの必要性を強調しています。HAIの一般的な例としては、肺炎、消化器疾患、尿路感染症、一次血流感染症、術後感染症などがあります。HAIの多発は世界中の政府にとって重大な関心事であり、このような事故を効果的に管理し、減少させることを目的とした政策の開発につながっています。英国医療安全保障局の2025年報告書によると、ヘルスケア関連感染は患者の7.6%に認められ、2016年と比較して1%増加しました。この調査は、増加傾向が懸念されることを浮き彫りにしており、英国のヘルスケア環境全体における感染予防・管理対策の強化の必要性を強調しています。

市場促進要因

院内感染の増加

主な市場課題

小規模ヘルスケア組織における導入コストの高さ

主な市場動向

クラウドベースのソフトウェアソリューション

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の感染監視ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 提供別（ソフトウェア、サービス）
  • エンドユーザー別（病院、長期ケア施設）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の感染監視ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の感染監視ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の感染監視ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の感染監視ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの感染監視ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の感染監視ソリューション市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Cerner Corporation
• Epic Systems Corporation
• VigiLanz Corporation
• Becton, Dickinson and Company
• Premier Inc.
• DEB Group Ltd
• RL Solutions
• Baxter International Inc.（ICNet International）
• Gojo Industries Inc.
• IBM Corporation（Truven Health Analytics）

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Infection Surveillance Solutions Market was valued at USD 557.21 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.16% through 2030F. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities.

For instance, in 2024, a study analyzing U.S. hospital data revealed that hospital-acquired infections linked to antimicrobial resistance (AMR) rose by 32% during the COVID-19 pandemic and remain 13% higher post-pandemic compared to pre-pandemic levels. The findings underscore the lasting impact of the pandemic on AMR and the need for sustained infection control and antimicrobial stewardship. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents. According to the UK Health Security Agency's 2025 report, healthcare-associated infections were found in 7.6% of patients-marking a 1% rise compared to 2016. The survey highlights a concerning upward trend, emphasizing the need for strengthened infection prevention and control measures across healthcare settings in the UK.

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control. For instance, in 2024, healthcare-associated infections impact approximately 4.3 million patients annually in hospitals across the EU/EEA. These infections pose significant challenges to patient safety, increase hospital stays, and contribute to higher healthcare costs. Reducing their incidence remains a critical priority for healthcare systems, requiring improved infection control practices and enhanced surveillance measures throughout the region.

The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.

Key Market Challenges

High Cost of Deployment for Small Healthcare Organizations

The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.

Key Market Trends

Cloud-based Software Solutions

Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. For instance, according to a 2022 article, 94% of companies worldwide have adopted cloud computing. This widespread adoption reflects the growing reliance on cloud-based technologies to enhance scalability, improve efficiency, and support digital transformation across various industries, making cloud computing a critical component of modern business operations. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.

Key Market Players

• Cerner Corporation
• Epic Systems Corporation
• VigiLanz Corporation
• Becton, Dickinson and Company
• Premier Inc.
• DEB Group Ltd
• RL Solutions
• Baxter International Inc. (ICNet International)
• Gojo Industries Inc.
• IBM Corporation (Truven Health Analytics)

Report Scope:

In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Surveillance Solutions Market, By Offering:

• Software
• Service

Infection Surveillance Solutions Market, By End User:

• Hospitals
• Long-term Care Facilities

Infection Surveillance Solutions Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Available Customizations:

Global Infection Surveillance Solutions market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Offering (Software, Service)
  • 5.2.2. By End User (Hospitals, Long-term Care Facilities)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Infection Surveillance Solutions Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Offering
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Infection Surveillance Solutions Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Offering
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Infection Surveillance Solutions Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Offering
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Infection Surveillance Solutions Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Offering
      • 6.3.3.2.2. By End User

7. Europe Infection Surveillance Solutions Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Offering
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Infection Surveillance Solutions Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Offering
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Infection Surveillance Solutions Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Offering
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Infection Surveillance Solutions Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Offering
      • 7.3.3.2.2. By End User
  • 7.3.4. France Infection Surveillance Solutions Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Offering
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Infection Surveillance Solutions Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Offering
      • 7.3.5.2.2. By End User

8. Asia-Pacific Infection Surveillance Solutions Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Offering
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Infection Surveillance Solutions Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Offering
      • 8.3.1.2.2. By End User
  • 8.3.2. India Infection Surveillance Solutions Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Offering
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Infection Surveillance Solutions Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Offering
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Infection Surveillance Solutions Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Offering
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Infection Surveillance Solutions Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Offering
      • 8.3.5.2.2. By End User

9. South America Infection Surveillance Solutions Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Offering
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Infection Surveillance Solutions Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Offering
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Infection Surveillance Solutions Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Offering
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Infection Surveillance Solutions Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Offering
      • 9.3.3.2.2. By End User

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Offering
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Infection Surveillance Solutions Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Offering
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Infection Surveillance Solutions Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Offering
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Infection Surveillance Solutions Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Offering
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Infection Surveillance Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cerner Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Epic Systems Corporation
• 15.3. VigiLanz Corporation
• 15.4. Becton, Dickinson and Company
• 15.5. Premier Inc.
• 15.6. DEB Group Ltd
• 15.7. RL Solutions
• 15.8. Baxter International Inc. (ICNet International)
• 15.9. Gojo Industries Inc.
• 15.10. IBM Corporation (Truven Health Analytics)

16. Strategic Recommendations

17. About Us & Disclaimer